ProMIS Neurosciences Cash And Cash Equivalents Were $1.2M As Of June 30, 2023, Compared To $5.9M As Of December 31, 2022.
Portfolio Pulse from Happy Mohamed
ProMIS Neurosciences' cash and cash equivalents have decreased from $5.9M as of December 31, 2022, to $1.2M as of June 30, 2023.
August 14, 2023 | 9:51 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ProMIS Neurosciences has seen a significant decrease in its cash and cash equivalents, from $5.9M at the end of 2022 to $1.2M by mid-2023.
The significant decrease in cash and cash equivalents indicates a potential liquidity issue for ProMIS Neurosciences. This could negatively impact the company's ability to fund operations and investments, which may lead to a negative investor sentiment and a potential decrease in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100